Lifecycle Partnership Capitalize on the Merck MilliporeSigma strategic partnership to market ProtaGene as an end to end analytics partner covering the full biopharma product lifecycle from development through GMP release, highlighting integrated protein and gene analysis capabilities and cross continental delivery.

Vector Analytics Position around vector safety, integration site analysis, and bioinformatics as a differentiated offering for gene and cell therapy developers, focusing on early stage programs, vector design validation, and regulatory submission support.

Global Footprint Leverage the four-site European and North American footprint to pursue global programs and multinational trials, offering synchronized analytics timelines, regulatory alignment, and scalable capacity.

Leadership Growth Highlight ongoing leadership investment and commercial expansion, including hires for Chief Scientific and Chief Commercial Officers, to drive multi year partnerships, portfolio expansion, and enterprise sales in biologics and cell therapies.

Advanced Analytics Target mid to large biotech and pharma customers seeking advanced analytics with proven growth and investment in new techniques such as differential scanning calorimetry and other high end analytics, positioning ProtaGene as a scalable partner for expansion projects and long term collaborations.